Literature DB >> 10653258

Coronary artery bypass and superior vena cava syndrome.

T V Thomas1, K Masrani, J L Thomas.   

Abstract

Superior vena cava syndrome is the obstruction of the superior vena cava or its main tributaries by benign or malignant lesions. The syndrome causes edema and engorgement of the vessels on the face, neck, and arms, nonproductive cough, and dyspnea. We discuss the case of a 48-year-old obese diabetic woman who was admitted with unstable angina. She had previously been diagnosed with superior vena cava syndrome. Urgent coronary artery bypass grafting was necessary Although thousands of coronary artery bypasses are performed every year, there are not many reports on patients with superior vena cava syndrome who successfully undergo cardiopulmonary bypass and coronary artery grafting with an internal mammary artery as the conduit. The results of the case and alternative recommended methods are discussed.

Entities:  

Mesh:

Year:  1999        PMID: 10653258      PMCID: PMC325666     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  5 in total

1.  Cerebral effects in superior vena caval cannula obstruction: the role of brain monitoring.

Authors:  R A Rodriguez; G Cornel; L Semelhago; W M Splinter; N A Weerasena
Journal:  Ann Thorac Surg       Date:  1997-12       Impact factor: 4.330

2.  Diagnostic anterior mediastinotomy.

Authors:  T V Thomas; H T Ransdell; A Borja
Journal:  Ann Thorac Surg       Date:  1969-01       Impact factor: 4.330

3.  Can a dilated coronary sinus produce left ventricular inflow obstruction? An unrecognized entity.

Authors:  A D Cochrane; A Marath; R B Mee
Journal:  Ann Thorac Surg       Date:  1994-10       Impact factor: 4.330

4.  Superior vena cava and central venous reconstruction.

Authors:  W M Moore; L H Hollier; T K Pickett
Journal:  Surgery       Date:  1991-07       Impact factor: 3.982

5.  Radiation-induced superior vena cava syndrome.

Authors:  Y Lee; R Doering; A Jihayel
Journal:  Tex Heart Inst J       Date:  1995
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.